Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound

NCT: NCT07287111 · COMPLETED

NCT IDNCT07287111
StatusCOMPLETED
Start Date2025-08-30
Completion2026-07-28
SponsorBeamWorks Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a retrospective, fully-crossed, multi-reader, multi-case (MRMC) study to evaluate the effectiveness of 'CadAI-B Dx' (CadAI-B) for decision support in breast ultrasound. The study compares the diagnostic performance of readers interpreting breast ultrasound images with and without the aid of CadAI-B. A total of 797 patient cases will be included, comprising 350 cases with a confirmed diagnosis of malignancy and 447 cases with a confirmed benign diagnosis. Sixteen readers will participate in the study to evaluate the device.

Frequently Asked Questions

What is Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound?

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound is a clinical trial registered under NCT07287111. Current status: COMPLETED.

What is the status of NCT07287111?

The current status of NCT07287111 (Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound) is: COMPLETED.

When did Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound start?

Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound started on 2025-08-30.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑